Characteristic Gut Bacteria in High Barley Consuming Japanese Individuals without Hypertension
- PMID: 37317220
- PMCID: PMC10223911
- DOI: 10.3390/microorganisms11051246
Characteristic Gut Bacteria in High Barley Consuming Japanese Individuals without Hypertension
Abstract
Background: Barley, a grain rich in soluble dietary fiber β-glucan, is expected to lower blood pressure. Conversely, individual differences in its effects on the host might be an issue, and gut bacterial composition may be a determinant.
Methods: Using data from a cross-sectional study, we examined whether the gut bacterial composition could explain the classification of a population with hypertension risks despite their high barley consumption. Participants with high barley intake and no occurrence of hypertension were defined as "responders" (n = 26), whereas participants with high barley intake and hypertension risks were defined as "non-responders" (n = 39).
Results: 16S rRNA gene sequencing revealed that feces from the responders presented higher levels of Faecalibacterium, Ruminococcaceae UCG-013, Lachnospira, and Subdoligranulum and lower levels of Lachnoclostridium and Prevotella 9 than that from non-responders. We further created a machine-learning responder classification model using random forest based on gut bacteria with an area under the curve value of 0.75 for estimating the effect of barley on the development of hypertension.
Conclusions: Our findings establish a link between the gut bacteria characteristics and the predicted control of blood pressure provided by barley intake, thereby providing a framework for the future development of personalized dietary strategies.
Keywords: barley; gut bacteria; hypertension; machine learning; stratification.
Conflict of interest statement
The department of Z.Y. has received research grants for other studies from Hakubaku Co., Ltd. S.M., T.M., M.N. and T.K. are employees of Hakubaku Co., Ltd.
Figures



References
-
- Beaney T., Schutte A.E., Tomaszewski M., Ariti C., Burrell L.M., Castillo R.R., Charchar F.J., Damasceno A., Kruger R., Lackland D.T., et al. May Measurement Month 2017: An Analysis of Blood Pressure Screening Results Worldwide. Lancet Glob. Health. 2018;6:e736–e743. doi: 10.1016/S2214-109X(18)30259-6. - DOI - PubMed
-
- GBD 2017 RiskFactor Collaborators Global, Regional, and National Comparative Risk Assessment of 84 Behavioural, Environmental and Occupational, and Metabolic Risks or Clusters of Risks for 195 Countries and Territories, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1923–1994. doi: 10.1016/S0140-6736(18)32225-6. - DOI - PMC - PubMed
-
- Roth G.A., Mensah G.A., Johnson C.O., Addolorato G., Ammirati E., Baddour L.M., Barengo N.C., Beaton A.Z., Benjamin E.J., Benziger C.P., et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update from the GBD 2019 Study. J. Am. Coll. Cardiol. 2020;76:2982–3021. doi: 10.1016/j.jacc.2020.11.010. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources